EFTA Document EFTA01457562
II May 2015 Pharmaceuticals GlaxoSmithKline Revised forecasts 'Figure 12; GSK revenue forecasts (Em); key categories/brands (Established Product detail omitted for space reasons) G8Pro FYi4/1 Pr 15E FYIGE P`I'l ?I Pel'OF FY18E FY19E Saccade,Ad...air 4.229 3.662 3.394 3,181 2,694 2,203 2,849 017 ReNar/Breo AvamysNeramyst 67 238 248 241 394 252 552 255 640 259 736 261 260 Flbrotide/Flovent 702 681 667 628 592 556 522 Ventolin 666 683 704 710 690 672
Summary
II May 2015 Pharmaceuticals GlaxoSmithKline Revised forecasts 'Figure 12; GSK revenue forecasts (Em); key categories/brands (Established Product detail omitted for space reasons) G8Pro FYi4/1 Pr 15E FYIGE P`I'l ?I Pel'OF FY18E FY19E Saccade,Ad...air 4.229 3.662 3.394 3,181 2,694 2,203 2,849 017 ReNar/Breo AvamysNeramyst 67 238 248 241 394 252 552 255 640 259 736 261 260 Flbrotide/Flovent 702 681 667 628 592 556 522 Ventolin 666 683 704 710 690 672
Ask AI About This Document
Extracted Text (OCR)
Related Documents (6)
EFTA Document EFTA01448830
O O OO zz "rt mm zz -i ); C C Al (/) z -1 C 0 Asset Account 0 73 R 7 ce TO JPMergan Chase Bank, NA. 270 Park Avenue, New York, NY 10017-2014 THE HAZE TRUST ACCT. For the Period 7/1/13 to 7/31/13 Z 0 6 8 6 O tW0 J.P. Morgan Team Table of Contents Palle Jusdn Nelson Banker 203/629-3124 Account Summary 2 Paul Barrett Investment Specialist 212/622-2770 Holdings Janet Young Client Service Team B001634-1318 Equity 4 Gina Magiiacco Cash & Reed Income
EFTA Document EFTA01361145
Growth Strategy returns Performance' for taxable client ending 3/31/15 CIO Strategies w/ U.S. Core Equity as U.S. Large Cap Vehicle ® Blended Benchmark 6 - 4 2 - 0 3.51 1.93 1Q15 C [0 Strategies .. Growth Blended Benchmark 9.78 8.30 8.42 4.15 1 Year 9.27 7.98 3 Year 5 Year °A Annualized Performance Gross of Fees 7.35 5.88 10 Year 7.07 2014 2013 2012 2011 2010 2009 2008 2007 4.84% 17.64% 14.43-;•:.. -2.94% 13.79% 29.09% 30.42% 12.52% 3.40% 16.25% 1
EFTA Document EFTA01488410
J.PMorgan Primary Account: For the Period 5129/10 to 6/30/10 Important Information About Your Statement In Case of Error. or (Natiloin About 1. our Electronic Funds Transfers Oil or unto bo the ILtt Waistlines tad me the I haw number .el Mateo on frau of itiorwni and noaconareners that l.P Magna Toon 0vitact infonnation youdunk ram' ginned or recapl is memo* or if yak axd more Informatics ah'ua do:aortic traria:non on a titarea or reatie We mita hati fimru no lam than f0 dayk anti we wan
EFTA Document EFTA01299716
RPTID: MBS01000 INCOMING/OUTGOING WIRES,CHECKS AND ACH REPORT PAGE: 1 DATE: 06/23/2017 IBD: EXE OFF: N4G ACCOUNT RR I/O C/W DESCRIPTION ADDITIONAL INFO BENEFICIARIES NET AMOUNT ISSUER NAME N40024950 ENS 0 W 121000248 6X 115000.00 WELLS FARGO BANK, NA SAN FRANCISCO CA HUMANITY PLUS 9572308337 N40904078 LW8 0 H SEND TO BANK FOR ACH ACH 021001088 619768827 340016774 L1A 0 H 011000028 00041178 STATE STREET BOSTON 12 EVERGREEN WAY BOSTON MA PAWLING NY 12564-1328 6X
EFTA Document EFTA01386401
Deutsche Bank Wealth Management AND US Deposits Base Currency USD Deutsche Bank Trust Company Americas Account Deposits Transactions From January 02, 2017 To March 07. 2018 Product Type NOW and SupeiNOW Accounts Value Date 03:0712V8 Market Value S( .I71.92) Transaction Activity from 01/02/2017 - 03/07/2018 Transaction Type Transaction Date Description To/From Funds Added (USD) Funds Subtracted (USD) 443105 L5 PAIN QUOTID€EN NEW YORK NY 01-08-17 SEQ # 700822286688 Total R
Deutsche Bank
DOJ EFTA Data Set 10 document EFTA01285353
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.